As a candidate gene for the development of obesity and diabetes, CD44 may be a key mediator of the systemic inflammation response associated with obesity and diabetes, participating in the regulation of inflammatory responses. This evidence concerns the gene CD44 and obesity due to melanocortin 4 receptor deficiency.